IRCT20200623047902N34招募中Unknown
Bioequivalence study of Fingolimod capsule 0.5 mg manufactured by Alborzzagros versus originator brand in healthy volunteers in the fasted condition
Alborz Zagros company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to fingolimod
研究者
相似试验
招募中
Unknown
Bioequivalence study of Fingolimod 0.5 mg capsuleIRCT20200105046010N92Abidi Company24
尚未招募
不适用
Study of absorption and elimination rate of Fingolimod 0.5-mg capsule in comparison with Fingolimod brand Capsule (Gilenya®).Bioequivalence study.IRCT20200407046981N26Zahravi pharmaceutical company24
已完成
1 期
Bioequivalence Study of a Test Capsule Formulation of Fingolimod With the Reference Capsule Formulation of FingolimodHealthy VolunteersNCT03757338Asofarma S.A.I. y C.33
尚未招募
1 期
A Bioequivalence Study of Two Formulations of 5 mg Montelukast Chewable Tablets in Healthy Thai Volunteers under Fasting ConditionsHealthy Thai VolunteersTCTR20210720012Siriraj Institute of Clinical Research (SICRES)28
招募中
Unknown
Anagrelide capsule BioequivalenceIRCT20130313012810N30Modava Pharmaceutical Company24